Compare ALEMBIC PHARMA with Jubilant Pharmova - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs JUBILANT PHARMOVA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA JUBILANT PHARMOVA ALEMBIC PHARMA/
JUBILANT PHARMOVA
 
P/E (TTM) x 17.5 12.8 135.9% View Chart
P/BV x 6.9 2.4 289.3% View Chart
Dividend Yield % 0.5 0.6 88.4%  

Financials

 ALEMBIC PHARMA   JUBILANT PHARMOVA
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
JUBILANT PHARMOVA
Mar-19
ALEMBIC PHARMA/
JUBILANT PHARMOVA
5-Yr Chart
Click to enlarge
High Rs664898 73.9%   
Low Rs412618 66.8%   
Sales per share (Unadj.) Rs208.7572.0 36.5%  
Earnings per share (Unadj.) Rs31.036.2 85.6%  
Cash flow per share (Unadj.) Rs37.159.5 62.4%  
Dividends per share (Unadj.) Rs5.504.50 122.2%  
Dividend yield (eoy) %1.00.6 172.1%  
Book value per share (Unadj.) Rs144.2301.9 47.8%  
Shares outstanding (eoy) m188.52159.28 118.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.61.3 194.7%   
Avg P/E ratio x17.420.9 83.0%  
P/CF ratio (eoy) x14.512.7 113.9%  
Price / Book Value ratio x3.72.5 148.7%  
Dividend payout %17.712.4 142.8%   
Avg Mkt Cap Rs m101,461120,694 84.1%   
No. of employees `000NA2.4 0.0%   
Total wages/salary Rs m7,46719,260 38.8%   
Avg. sales/employee Rs ThNM38,120.6-  
Avg. wages/employee Rs ThNM8,058.4-  
Avg. net profit/employee Rs ThNM2,414.3-  
INCOME DATA
Net Sales Rs m39,34791,108 43.2%  
Other income Rs m94357 26.2%   
Total revenues Rs m39,44191,466 43.1%   
Gross profit Rs m8,73617,390 50.2%  
Depreciation Rs m1,1523,709 31.1%   
Interest Rs m1842,198 8.4%   
Profit before tax Rs m7,49311,840 63.3%   
Minority Interest Rs m110-   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m0-2,802 0.0%   
Tax Rs m1,5683,268 48.0%   
Profit after tax Rs m5,8445,770 101.3%  
Gross profit margin %22.219.1 116.3%  
Effective tax rate %20.927.6 75.8%   
Net profit margin %14.96.3 234.5%  
BALANCE SHEET DATA
Current assets Rs m19,57745,848 42.7%   
Current liabilities Rs m14,89620,897 71.3%   
Net working cap to sales %11.927.4 43.4%  
Current ratio x1.32.2 59.9%  
Inventory Days Days9057 158.0%  
Debtors Days Days4551 89.0%  
Net fixed assets Rs m27,09765,498 41.4%   
Share capital Rs m377159 236.7%   
"Free" reserves Rs m26,81147,930 55.9%   
Net worth Rs m27,18848,089 56.5%   
Long term debt Rs m4,99342,429 11.8%   
Total assets Rs m47,778114,685 41.7%  
Interest coverage x41.76.4 653.0%   
Debt to equity ratio x0.20.9 20.8%  
Sales to assets ratio x0.80.8 103.7%   
Return on assets %12.66.9 181.6%  
Return on equity %21.512.0 179.1%  
Return on capital %23.612.4 190.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m19,45312,422 156.6%   
Fx outflow Rs m6,06517,227 35.2%   
Net fx Rs m13,388-4,805 -278.6%   
CASH FLOW
From Operations Rs m8,12011,215 72.4%  
From Investments Rs m-7,556-10,118 74.7%  
From Financial Activity Rs m5906,574 9.0%  
Net Cashflow Rs m1,1537,612 15.2%  

Share Holding

Indian Promoters % 74.1 45.6 162.5%  
Foreign collaborators % 0.0 3.5 -  
Indian inst/Mut Fund % 2.9 8.7 33.3%  
FIIs % 9.1 21.2 42.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 21.1 65.9%  
Shareholders   49,328 23,815 207.1%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   DR. DATSONS LABS  DISHMAN PHARMA  J.B.CHEMICALS  TORRENT PHARMA  BIOCON   

Compare ALEMBIC PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY20); Net Profit Up 358.8% (Quarterly Result Update)

Jun 1, 2020 | Updated on Jun 1, 2020

For the quarter ended March 2020, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 358.8% YoY). Sales on the other hand came in at Rs 24 bn (up 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY20); Net Profit Down 24.0% (Quarterly Result Update)

Feb 1, 2020 | Updated on Feb 1, 2020

For the quarter ended December 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 24.0% YoY). Sales on the other hand came in at Rs 23 bn (down 2.6% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

An India Revival Stock I'm Bullish On...(Profit Hunter)

Apr 9, 2021

This could take India to the position of 3rd largest economy.

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

Why the Market Fell Yesterday(Fast Profits Daily)

Apr 6, 2021

In this video, I'll tell you the two reasons why the market fell on Monday and how you can prepare yourself for such events in the future.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Apr 16, 2021 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS